Dextrose
As of the edition of 20 October 2026, Dextrose is a small molecule: marketed, first approved in 1951 (CA).
Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.
The drug
- Status
- Marketed; latest approval 1983
- Kind
- Small molecule
- Brand name
- Dextrose 5% In Plastic Container
- First approved
- 31 December 1951 (CA)
- Approvals on record
- 545 in 6 regions
- Holder of the most recent approval
- B. Braun Medical; 23 holders in all
- Registered trials
- 122, 17 stopped early
- Disease areas
- Nutrition and metabolism; Hormones; Immune system; Nervous system; Urinary and reproductive; Bones, joints and muscles
US protection
No US approval on record.
With no US approval on record there are no listed US patents or exclusivities.
This is the US only.
Registered trials
| Phase | Trials | Completed | Active | Stopped early |
|---|---|---|---|---|
| Phase not stated | 52 | 31 | 7 | 5 |
| Phase 1 | 20 | 14 | 3 | 2 |
| Phase 2 | 14 | 5 | 3 | 2 |
| Phase 3 | 15 | 4 | 3 | 5 |
| Phase 4 | 21 | 11 | 3 | 3 |
| All trials | 122 |
Who has held its approvals
| Company | Role | Years |
|---|---|---|
| B. Braun Medical | Applicant and Later holder | 1963 to now |
| Pfizer | Applicant and Acquired holder | 1968 to now |
| Baxter Healthcare | Applicant and Later holder | 1973 to now |
| Alcon | Later holder | 1982 to now |
| Dhl | Later holder | 1995 to now |
| Abbott | Acquired holder and Later holder | 1998 to now |
| Otsuka | Acquired holder | 2025 to now |
| Bayer | Later holder |